Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter Impact of Adherence to Medical Therapy on Comparative Outcomes
暂无分享,去创建一个
[1] D. Hoffman,et al. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting. , 2015, Journal of the American College of Cardiology.
[2] S. Pocock,et al. Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. , 2015, Journal of the American College of Cardiology.
[3] Shengshou Hu,et al. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery , 2015, Circulation.
[4] E. Steyerberg,et al. Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Fol , 2015, Circulation.
[5] Stacey L. Sheridan,et al. Quantifying the Utility of Taking Pills for Cardiovascular Prevention , 2015, Circulation. Cardiovascular quality and outcomes.
[6] J. Vlayen,et al. Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis. , 2015, The Journal of thoracic and cardiovascular surgery.
[7] A. Jaffe,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[8] E. Peterson,et al. Revascularization in stable coronary artery disease. , 2014, JAMA.
[9] I. Sipahi,et al. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. , 2014, JAMA Internal Medicine.
[10] E. Tuzcu,et al. Late Stroke: Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Multivessel Disease and Unprotected Left Main Disease A Meta-Analysis and Review of Literature , 2014, Stroke.
[11] H. Wijeysundera,et al. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. , 2013, JAMA.
[12] A. Raval,et al. Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[13] M. Mack,et al. Coronary Artery Revascularization Evaluation—A Multicenter Registry With Seven Years of Follow‐Up , 2013, Journal of the American Heart Association.
[14] Sankey V. Williams,et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.
[15] H. Pfaff,et al. Physicians' knowledge of and compliance with guidelines: an exploratory study in cardiovascular diseases. , 2011, Deutsches Arzteblatt international.
[16] Ben A. Williams,et al. Perils of Evidence-Based Medicine , 2010, Perspectives in biology and medicine.
[17] P Michael Ho,et al. Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.
[18] M. Mack,et al. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. , 2008, The Annals of thoracic surgery.
[19] A. Lippman. Adherence to medication. , 2005, The New England journal of medicine.
[20] M. J. Cuevas,et al. Assessment of Adherence to Triple Antiretroviral Treatment Including Indinavir: Role of the Determination of Plasma Levels of Indinavir , 2003, Journal of acquired immune deficiency syndromes.
[21] N. Maggiano,et al. Localization of nitric oxide synthase type III in the internal thoracic and radial arteries and the great saphenous vein: a comparative immunohistochemical study. , 2003, The Journal of thoracic and cardiovascular surgery.
[22] R Brian Haynes,et al. Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.
[23] Muhammad Mamdani,et al. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.
[24] M. Robin DiMatteo,et al. Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis , 2002, Medical care.
[25] Sundhiya Mandalia,et al. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome , 2002, AIDS.
[26] M. Chesney,et al. Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. , 2001, Journal of clinical epidemiology.
[27] S. Kitamura,et al. Difference in acetylcholine-induced nitric oxide release of arterial and venous grafts in patients after coronary bypass operations. , 1998, The Journal of thoracic and cardiovascular surgery.
[28] S. Woolf. Practice guidelines: a new reality in medicine. III. Impact on patient care. , 1993, Archives of internal medicine.
[29] M. Enkin,et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. , 1989, The New England journal of medicine.
[30] D. Sackett,et al. Can Simple Clinical Measurements Detect Patient Noncompliance? , 1980, Hypertension.
[31] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.